Furthermore, given that the p53 status has an important role in regulating DOX sensitivity of breast cancer resistant cells [63,64,65], we examined whether a breast cancer cell line expressing mutant p53 yields a different response. The gene discussed is TP53; the disease is breast carcinoma.